You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -4.5 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 3.9 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | n/a | -3.21 | -8.37p | -17.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -6.01 | -11.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -5.52 | -10.66p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -6.48 | -12.00p | -5.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -6.27 | -8.90p | -11.8 | 0.0 | n/a | n/a | 0.0% |
| Destiny Pharma awarded Cystic Fibrosis Foundation project Sharecast News | 12 Jul |
|---|---|
| Destiny Pharma appoints Yuri Martina as chief medical officer Sharecast News | 03 May |
| Destiny Pharma to raise up to £7m in discounted fundraising Sharecast News | 08 Mar |
| Chair’s Investor Update | 28-Jul-22 07:00 |
|---|---|
| Publication of new data on NTCD-M3 | 26-Jul-22 07:00 |
| Positive update from US FDA on XF-73 Phase 3 | 19-Jul-22 07:00 |
| Grant from the Cystic Fibrosis Foundation | 12-Jul-22 07:00 |
| Publication of XF-73 drug synergy data | 07-Jul-22 07:00 |